RYAN SPECIALTY HOLDINGS, INC. (RYAN) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 2.16%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 2.16% | Share-based compensation / revenue. Period ending 2026-06-30. $68.39M ÷ $3.16B × 100 ≈ 2.16% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 3.16B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 68.39M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 477.26M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $3.16B | $68.39M | $477.26M | (m) | (m) | 2.16% | (m) | (m) |
| 2026-03-31 | (m) | $3.10B | $66.93M | $488.00M | (m) | (m) | 2.16% | (m) | (m) |
| 2025-12-31 | (m) | $2.99B | $69.45M | $493.64M | (m) | (m) | 2.32% | (m) | (m) |
| 2025-09-30 | (m) | $2.91B | $68.32M | $511.40M | (m) | (m) | 2.35% | (m) | (m) |
| 2025-06-30 | (m) | $2.75B | $80.59M | $482.08M | (m) | (m) | 2.93% | (m) | (m) |
| 2025-03-31 | (m) | $2.59B | $81.56M | $455.40M | (m) | (m) | 3.14% | (m) | (m) |
| 2024-12-31 | (m) | $2.46B | $79.00M | $427.81M | (m) | (m) | 3.22% | (m) | (m) |
| 2024-09-30 | (m) | $2.38B | $77.27M | $414.83M | (m) | (m) | 3.25% | (m) | (m) |
| 2024-06-30 | (m) | $2.28B | $71.42M | $403.17M | $121.69M | (m) | 3.13% | 3.31× | Reported |
| 2024-03-31 | (m) | $2.17B | $69.17M | $361.64M | $119.44M | (m) | 3.18% | 3.03× | Reported |
| 2023-12-31 | (m) | $2.08B | $69.74M | $359.08M | $119.51M | (m) | 3.36% | 3.00× | Reported |
| 2023-09-30 | (m) | $1.98B | $70.53M | $341.99M | $119.21M | (m) | 3.56% | 2.87× | Reported |
| 2023-06-30 | (m) | $1.89B | $70.98M | $333.52M | $116.58M | (m) | 3.76% | 2.86× | Reported |
| 2023-03-31 | (m) | $1.80B | $72.11M | $316.21M | $112.55M | (m) | 4.02% | 2.81× | Reported |
| 2022-12-31 | (m) | $1.73B | $77.48M | $289.51M | $104.83M | (m) | 4.49% | 2.76× | Reported |
| 2022-09-30 | (m) | $1.67B | $81.74M | $265.51M | $94.59M | (m) | 4.90% | 2.81× | Reported |
| 2022-06-30 | (m) | $1.61B | $102.97M | $203.43M | $86.92M | (m) | 6.40% | 2.34× | Reported |
| 2022-03-31 | (m) | $1.51B | $86.35M | $190.17M | $81.06M | (m) | 5.73% | 2.35× | Reported |
| 2021-12-31 | (m) | $1.43B | $67.53M | $186.62M | $79.35M | (m) | 4.71% | 2.35× | Reported |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | $1.02B | $10.80M | $158.54M | $47.24M | (m) | 1.06% | 3.36× | Reported |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | $765.11M | $8.15M | $101.04M | $35.55M | (m) | 1.07% | 2.84× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CORVEL CORP (CRVL) | United States | $3.727B | 27.41 |
| Baldwin Insurance Group, Inc. (BWIN) | United States | $1.083B | -498.48 |
| Goosehead Insurance, Inc. (GSHD) | United States | $0.922B | 276.12 |
| Roadzen Inc. (RDZN) | United States | $0.109B | |
| SelectQuote, Inc. (SLQT) | United States | $0.073B | 2.34 |
| eHealth, Inc. (EHTH) | United States | $0.026B | 1.75 |
| Reliance Global Group, Inc. (EZRA) | United States | $0.003B | |
| Equitable Holdings, Inc. (EQH) | United States | $14.367B | -12.94 |
| BROWN & BROWN, INC. (BRO) | United States | $20.190B | 17.57 |
| WILLIS TOWERS WATSON PLC (WTW) | $27.268B | 15.77 |